Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Sulfamethoxazole And Trimethoprim
Brand Name
Sulfamethoxazole And Trimethoprim
Generic Name
Sulfamethoxazole And Trimethoprim
Active Ingredient
SulfamethoxazoleCategory
Sulfonamide Antimicrobial [EPC]
Variants
98
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Sulfamethoxazole And Trimethoprim, you must consult a qualified healthcare professional.
| 800 mg/1 | TABLET | ORAL | 70518-0863 |
| 800 mg/1 | TABLET | ORAL | 82868-092 |
| 200 mg/5mL | SUSPENSION | ORAL | 17856-0496 |
| 800 mg/1 | TABLET | ORAL | 42291-759 |
| 200 mg/5mL | SUSPENSION | ORAL | 50090-0525 |
| 800 mg/1 | TABLET | ORAL | 50090-6904 |
| 800 mg/1 | TABLET | ORAL | 50090-7399 |
| 800 mg/1 | TABLET | ORAL | 51655-188 |
| 800 mg/1 | TABLET | ORAL | 60429-259 |
+ 38 more variants
Detailed information about Sulfamethoxazole And Trimethoprim
Sulfamethoxazole is a sulfonamide antibiotic used primarily in combination with trimethoprim to treat a wide variety of bacterial infections, including urinary tract infections and pneumonia. It works by inhibiting bacterial folic acid synthesis, a process essential for microbial growth.
Dosage for Sulfamethoxazole is highly dependent on the type and severity of the infection being treated. Because it is almost exclusively prescribed as a combination product (SMZ/TMP), doses are often expressed in terms of the double-strength (DS) tablet.
Sulfamethoxazole is approved for use in infants older than two months of age. It is strictly contraindicated (must not be used) in infants younger than two months due to the risk of kernicterus (a type of brain damage caused by high bilirubin levels).
Because Sulfamethoxazole is primarily cleared by the kidneys, patients with reduced kidney function require careful monitoring and dosage modification to prevent toxic accumulation.
Sulfamethoxazole should be used with extreme caution in patients with significant liver damage. There is no specific formula for dose reduction, but healthcare providers will monitor liver function tests (LFTs) closely during therapy.
Older adults are at an increased risk for severe adverse reactions, particularly if they are taking other medications like diuretics (water pills) or ACE inhibitors. Dosing should be conservative, often starting at the lower end of the range, while monitoring renal function and potassium levels.
To ensure the best outcomes and minimize side effects, follow these administration guidelines:
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular schedule. Do not 'double up' or take two doses at once to make up for a missed one.
Signs of an acute Sulfamethoxazole overdose may include nausea, vomiting, dizziness, headache, mental depression, and confusion. Chronic overexposure may lead to bone marrow suppression (seen as low blood cell counts). In case of a suspected overdose, contact a Poison Control Center or seek emergency medical attention immediately. Treatment is generally supportive and may include gastric lavage (stomach pumping) and forced fluids to aid renal excretion.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the medication without medical guidance.
Most patients tolerate Sulfamethoxazole well, but some may experience mild to moderate side effects. Common reactions include:
Sulfamethoxazole is a powerful antimicrobial that carries significant risks if not used appropriately. The most critical safety point is the risk of severe allergic reactions. Patients with a known 'sulfa allergy' must never take this medication. Furthermore, because it can affect the blood and kidneys, patients must remain under medical supervision during the entire course of therapy.
No FDA black box warnings for Sulfamethoxazole exist as a standalone entity, but the combination products (Sulfamethoxazole/Trimethoprim) carry severe warnings regarding potential fatalities from skin and blood disorders. These warnings serve as a directive to clinicians to monitor patients for any signs of hematologic (blood) or dermatologic (skin) changes.
In these specific scenarios, Sulfamethoxazole must NEVER be used because the risks significantly outweigh any potential benefit:
Sulfamethoxazole is generally classified as FDA Pregnancy Category D. It should be avoided during the first trimester (due to the risk of birth defects like neural tube defects, as it interferes with folic acid) and during the final month of pregnancy (due to the risk of kernicterus in the infant). It should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus, and typically only if no safer alternatives are available.
Sulfamethoxazole is excreted in human breast milk. While generally considered compatible with breastfeeding for healthy, full-term infants, it should be avoided if the infant is premature, has hyperbilirubinemia (jaundice), or has G6PD deficiency. There is a theoretical risk of kernicterus in the nursing infant.
As noted, Sulfamethoxazole is contraindicated in infants less than 2 months old. For older children, it is a common and effective treatment for ear infections and UTIs. Dosing must be strictly calculated based on the child's weight to avoid toxicity. Long-term use in children requires monitoring of growth and blood counts.
Sulfamethoxazole is a competitive inhibitor of the bacterial enzyme dihydropteroate synthase. It is a structural analog of para-aminobenzoic acid (PABA). By competing with PABA, it prevents the synthesis of dihydropteroic acid, which is a critical precursor to tetrahydrofolic acid (the active form of folate). Without folate, bacteria cannot synthesize thymidine and purines, which are the building blocks of DNA. This leads to a halt in bacterial growth and replication (bacteriostatic effect).
The antibacterial activity of Sulfamethoxazole is time-dependent. Its efficacy is best predicted by the amount of time the drug concentration remains above the Minimum Inhibitory Concentration (MIC) of the target pathogen. When combined with trimethoprim, the two drugs exhibit synergistic activity, meaning their combined effect is much greater than the sum of their individual parts. This synergy also expands the spectrum of activity to include organisms that might be resistant to either drug alone.
| Parameter | Value |
|---|---|
Common questions about Sulfamethoxazole And Trimethoprim
Sulfamethoxazole is a sulfonamide antibiotic primarily used to treat various bacterial infections, most commonly urinary tract infections (UTIs) and respiratory tract infections. It is also a critical medication for treating and preventing Pneumocystis jirovecii pneumonia, a serious infection in people with weakened immune systems. Additionally, it can be used for ear infections in children, traveler's diarrhea, and certain intestinal infections like shigellosis. It is almost always prescribed in combination with trimethoprim to increase its effectiveness and prevent bacterial resistance. Your doctor will determine if this antibiotic is appropriate based on the specific type of bacteria causing your infection.
The most frequent side effects reported by patients taking Sulfamethoxazole include nausea, vomiting, and a loss of appetite. Some individuals may also develop a mild skin rash or experience increased sensitivity to sunlight, which can lead to easier sunburns. Dizziness and headaches are also relatively common but usually mild. While these symptoms are often manageable, it is essential to report any new rash or persistent stomach issues to your healthcare provider immediately. Most mild side effects resolve once the course of treatment is finished and the drug leaves your system.
It is generally recommended to avoid alcohol while taking Sulfamethoxazole. While it does not typically cause the severe 'Antabuse-like' reaction (severe vomiting) associated with some other antibiotics, alcohol can interfere with your body's ability to fight infection and may worsen side effects like dizziness or stomach upset. Furthermore, both alcohol and Sulfamethoxazole are processed by the liver, and alcohol consumption can lead to dehydration, which increases the risk of kidney-related side effects from the medication. Staying well-hydrated with water is a priority during treatment. Always consult your doctor for specific advice regarding alcohol consumption and your medications.
Sulfamethoxazole is generally not recommended during the first trimester of pregnancy or during the final month before delivery. In the first trimester, it may interfere with folic acid levels, which are crucial for the baby's neural tube development. In the final weeks of pregnancy, there is a risk that the drug could cause 'kernicterus' (a dangerous buildup of bilirubin in the brain) in the newborn baby. If you are pregnant or planning to become pregnant, your doctor will likely choose a safer alternative antibiotic unless the infection is life-threatening and no other options exist. Always inform your healthcare provider if you are pregnant before starting this medication.
Most patients begin to feel an improvement in their symptoms within 24 to 48 hours of starting Sulfamethoxazole. For a urinary tract infection, for example, burning and frequency usually diminish quickly. However, even if you feel completely better, it is vital to finish the entire prescribed course of the medication. The bacteria may still be present in small amounts, and stopping the drug early can lead to a relapse or the development of antibiotic-resistant bacteria. If your symptoms do not improve at all after three days of treatment, you should contact your healthcare provider.
You should not stop taking Sulfamethoxazole suddenly unless you experience a serious allergic reaction, such as a skin rash, hives, or difficulty breathing. If you stop the antibiotic too soon because you feel better, the infection may return and be harder to treat the second time. This is because the most resilient bacteria are often the last to be cleared by the medication. If you are experiencing bothersome but non-serious side effects, talk to your doctor about how to manage them rather than stopping the drug. If a serious reaction occurs, stop the drug immediately and seek medical attention.
If you miss a dose of Sulfamethoxazole, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Never take two doses at the same time to make up for a missed one, as this can increase your risk of side effects. Consistency is key to keeping enough of the antibiotic in your system to fight the infection effectively. Setting a timer or using a pill organizer can help you stay on track with your medication schedule.
Weight gain is not a known or typical side effect of Sulfamethoxazole. In fact, because the drug can cause nausea and a loss of appetite in some patients, temporary weight loss is more common than weight gain during a short course of treatment. If you notice rapid weight gain or unusual swelling in your ankles or feet while taking this medication, you should contact your doctor immediately. Such swelling could be a sign of kidney problems or other underlying issues rather than a direct effect of the medication on body fat. Always report unexpected physical changes to your medical team.
Sulfamethoxazole has several significant drug interactions that require careful management. It can dangerously increase the effects of blood thinners like warfarin, leading to a high risk of bleeding. It also interacts with certain blood pressure medications (like Lisinopril) and diabetes drugs, potentially causing high potassium levels or low blood sugar. Because of these risks, it is crucial to provide your doctor with a complete list of all prescriptions, over-the-counter medicines, vitamins, and herbal supplements you are currently taking. Your doctor may need to adjust your dosages or monitor your blood work more frequently while you are on the antibiotic.
Yes, Sulfamethoxazole is widely available as a generic medication, almost always in its combined form with trimethoprim. Generic versions are typically much more affordable than brand-name versions like Bactrim or Septra and are required by the FDA to have the same quality, strength, and purity. Because it is a long-standing and commonly used antibiotic, most insurance plans cover the generic version with a low co-pay. You can discuss with your pharmacist whether a generic version is appropriate for your prescription. The effectiveness of the generic is identical to the brand-name drug.
Other drugs with the same active ingredient (Sulfamethoxazole)
> Warning: Stop taking Sulfamethoxazole and call your doctor immediately if you experience any of these serious symptoms. These reactions can be life-threatening.
Prolonged use of Sulfamethoxazole can lead to fungal overgrowth (such as oral thrush or vaginal yeast infections). It may also lead to chronic folate deficiency in susceptible individuals, which can cause a type of anemia called megaloblastic anemia. Long-term use requires periodic blood monitoring to ensure the bone marrow and kidneys are functioning correctly.
There are currently no specific FDA 'Black Box' warnings for Sulfamethoxazole alone; however, the labels for combination products (like Bactrim) contain prominent warnings regarding the risk of fatal skin reactions (SJS/TEN) and the necessity of discontinuing the drug at the first sign of a skin rash. The FDA emphasizes that deaths associated with the administration of sulfonamides, although rare, have occurred due to severe reactions including fulminant hepatic necrosis, agranulocytosis, and other blood dyscrasias.
Report any unusual symptoms to your healthcare provider. You may also report side effects to the FDA at 1-800-FDA-1088.
If you are on Sulfamethoxazole for more than 14 days, or if you are at high risk for complications, your healthcare provider will likely order the following tests:
Sulfamethoxazole may cause dizziness or fatigue in some individuals. Until you know how this medication affects you, use caution when driving, operating heavy machinery, or performing tasks that require mental alertness.
While there is no direct chemical interaction that causes a 'disulfiram-like reaction' (severe vomiting) with Sulfamethoxazole alone, alcohol can dehydrate the body and strain the liver. It is generally advised to avoid or limit alcohol consumption during antibiotic therapy to allow the body to recover and to maintain proper hydration.
Unlike some psychiatric or blood pressure medications, Sulfamethoxazole does not require a tapering schedule. However, it is vital not to discontinue the drug prematurely just because symptoms have improved. Early discontinuation can lead to a relapse of the infection and the development of antibiotic-resistant bacteria. If you must stop the drug due to a side effect (like a rash), contact your doctor immediately for an alternative treatment.
> Important: Discuss all your medical conditions, especially kidney disease, liver disease, or blood disorders, with your healthcare provider before starting Sulfamethoxazole.
Sulfamethoxazole can interfere with certain laboratory tests, leading to inaccurate results:
For each major interaction, the mechanism usually involves the inhibition of the CYP2C9 enzyme or competitive renal secretion. The clinical consequence is typically an increased risk of toxicity from the 'victim' drug. Management strategies always involve frequent blood monitoring and potential dose adjustments by a qualified healthcare professional.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter drugs.
These conditions require a careful risk-benefit analysis by a physician:
Patients allergic to 'sulfa' antibiotics may also react to other sulfonamide-containing drugs, such as certain 'water pills' (thiazide diuretics), some oral diabetes medications (sulfonylureas), and certain carbonic anhydrase inhibitors. However, the risk of cross-reactivity between antibiotic sulfonamides and non-antibiotic sulfonamides is considered low by many experts; regardless, a thorough medical history is essential.
> Important: Your healthcare provider will evaluate your complete medical history, including any previous drug reactions, before prescribing Sulfamethoxazole.
Elderly patients (over 65) are at the highest risk for severe adverse reactions to Sulfamethoxazole. This includes a higher incidence of severe skin reactions, bone marrow suppression, and hyperkalemia. These risks are often compounded by age-related declines in kidney function and the use of other medications (polypharmacy). In older adults taking diuretics or ACE inhibitors, the risk of fatal hyperkalemia is a significant concern.
For patients with a Glomerular Filtration Rate (GFR) or Creatinine Clearance between 15 and 30 mL/min, the dosage must be reduced by half. If the GFR falls below 15 mL/min, the drug is generally not recommended. For patients on hemodialysis, a supplemental dose may be required after the dialysis session, as the drug is partially removed by the procedure.
There are no specific guidelines based on Child-Pugh classification, but Sulfamethoxazole should be used with extreme caution. The liver is responsible for acetylating the drug; impaired liver function can lead to altered metabolism and increased risk of both liver toxicity and systemic side effects.
> Important: Special populations require individualized medical assessment and frequent monitoring by a healthcare team.
| Protein Binding | ~70% |
| Half-life | 10 hours (Adults) |
| Tmax | 1–4 hours |
| Metabolism | Hepatic (Acetylation, Glucuronidation) |
| Excretion | Renal (80% as metabolites, 20% unchanged) |
Sulfamethoxazole is classified as a Sulfonamide Antimicrobial. It belongs to the broader category of 'Sulfa Drugs.' Related medications include sulfadiazine and sulfisoxazole. In modern medicine, it is almost exclusively categorized as part of the 'folate antagonist' group when used in combination with trimethoprim.